[Deleterious impact of a non-steroidal anti-inflammatory taken for fever or acute pain in case of streptococcal infection].

IF 2.2 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Annie-Pierre Jonville-Bera, Joëlle Micallef
{"title":"[Deleterious impact of a non-steroidal anti-inflammatory taken for fever or acute pain in case of streptococcal infection].","authors":"Annie-Pierre Jonville-Bera, Joëlle Micallef","doi":"10.1016/j.therap.2025.02.012","DOIUrl":null,"url":null,"abstract":"<p><p>For several years, regional pharmacovigilance centers have been warning about the risk of worsening bacterial skin or lung infections caused by Streptococcus pyogenes or Pneumococcus after taking non-steroidal anti-inflammatory drugs (NSAIDs), particularly ibuprofen. A new report submitted to the French Medicines Agency in 2024 documented 216 cases of serious bacterial infections (162 with ibuprofen, 54 with ketoprofen) over 4.5 years following the use of NSAIDs for fever or acute pain. This represents about 21% of serious adverse events with ibuprofen (8% with ketoprofen). Streptococcal infections were most common with ibuprofen (62% of serious bacterial infections; 44% with ketoprofen). These streptococcal infections were invasive (97%) and included severe sepsis/toxic shock, pleuropneumopathy, meningitis/meningoencephalitis and necrotizing dermohypodermatitis. Pharmacoepidemiological studies all suggest an association between NSAID exposure and an increased risk of pleuropulmonary complications, with estimated risks ranging from 1.8 to 8. Several mechanistic data also suggest a specific adverse effect on the severity of invasive streptococcal infections through a specific intrinsic effect of NSAIDs on the enhancement of streptococcal diffusion (via vimentin). Experimental studies in animals have also demonstrated this risk, even when NSAIDs are combined with antibiotics. In conclusion, in the presence of a streptococcal infection, whether diagnosed or not, taking an NSAID for fever or acute pain, even for a short time and even in association with an antibiotic, is a risky practice. It encourages the development of a more serious streptococcal infection, not only by delaying management of the infection, but more importantly by promoting the dissemination of the streptococcus. As invasive S. pyogenes infections are a real public health problem, any potential risk factor for aggravation must be taken into account.</p>","PeriodicalId":23147,"journal":{"name":"Therapie","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.therap.2025.02.012","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

For several years, regional pharmacovigilance centers have been warning about the risk of worsening bacterial skin or lung infections caused by Streptococcus pyogenes or Pneumococcus after taking non-steroidal anti-inflammatory drugs (NSAIDs), particularly ibuprofen. A new report submitted to the French Medicines Agency in 2024 documented 216 cases of serious bacterial infections (162 with ibuprofen, 54 with ketoprofen) over 4.5 years following the use of NSAIDs for fever or acute pain. This represents about 21% of serious adverse events with ibuprofen (8% with ketoprofen). Streptococcal infections were most common with ibuprofen (62% of serious bacterial infections; 44% with ketoprofen). These streptococcal infections were invasive (97%) and included severe sepsis/toxic shock, pleuropneumopathy, meningitis/meningoencephalitis and necrotizing dermohypodermatitis. Pharmacoepidemiological studies all suggest an association between NSAID exposure and an increased risk of pleuropulmonary complications, with estimated risks ranging from 1.8 to 8. Several mechanistic data also suggest a specific adverse effect on the severity of invasive streptococcal infections through a specific intrinsic effect of NSAIDs on the enhancement of streptococcal diffusion (via vimentin). Experimental studies in animals have also demonstrated this risk, even when NSAIDs are combined with antibiotics. In conclusion, in the presence of a streptococcal infection, whether diagnosed or not, taking an NSAID for fever or acute pain, even for a short time and even in association with an antibiotic, is a risky practice. It encourages the development of a more serious streptococcal infection, not only by delaying management of the infection, but more importantly by promoting the dissemination of the streptococcus. As invasive S. pyogenes infections are a real public health problem, any potential risk factor for aggravation must be taken into account.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapie
Therapie 医学-药学
CiteScore
3.50
自引率
7.70%
发文量
132
审稿时长
57 days
期刊介绍: Thérapie is a peer-reviewed journal devoted to Clinical Pharmacology, Therapeutics, Pharmacokinetics, Pharmacovigilance, Addictovigilance, Social Pharmacology, Pharmacoepidemiology, Pharmacoeconomics and Evidence-Based-Medicine. Thérapie publishes in French or in English original articles, general reviews, letters to the editor reporting original findings, correspondence relating to articles or letters published in the Journal, short articles, editorials on up-to-date topics, Pharmacovigilance or Addictovigilance reports that follow the French "guidelines" concerning good practice in pharmacovigilance publications. The journal also publishes thematic issues on topical subject. The journal is indexed in the main international data bases and notably in: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信